Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant add-on to sodium oxybate for residual excessive daytime sleepiness in narcolepsy
2011-000084-27Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in narcolepsy comparing Pitolisant add-on to sodium oxybate with Placebo add-on to sodium oxybate (2 arms). Primary endpoint: Change in excessive daytime sleepiness by Epworth Sleepiness Scale. Started Feb 2012; status: completed.
02
Drugs
pitolisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on 2011-000084-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000084-27.